Dataset Information


The ?v?6 integrin in cancer cell-derived small extracellular vesicles enhances angiogenesis.

ABSTRACT: Prostate cancer (PrCa) cells crosstalk with the tumour microenvironment by releasing small extracellular vesicles (sEVs). sEVs, as well as large extracellular vesicles (LEVs), isolated via iodixanol density gradients from PrCa cell culture media, express the epithelial-specific ?v?6 integrin, which is known to be induced in cancer. In this study, we show sEV-mediated protein transfer of ?v?6 integrin to microvascular endothelial cells (human microvascular endothelial cells 1 - HMEC1) and demonstrate that de novo ?v?6 integrin expression is not caused by increased mRNA levels. Incubation of HMEC1 with sEVs isolated from PrCa PC3 cells that express the ?v?6 integrin results in a highly significant increase in the number of nodes, junctions and tubules. In contrast, incubation of HMEC1 with sEVs isolated from ?6 negative PC3 cells, generated by shRNA against ?6, results in a reduction in the number of nodes, junctions and tubules, a decrease in survivin levels and an increase in a negative regulator of angiogenesis, pSTAT1. Furthermore, treatment of HMEC1 with sEVs generated by CRISPR/Cas9-mediated down-regulation of ?6, causes up-regulation of pSTAT1. Overall, our findings suggest that ?v?6 integrin in cancer sEVs regulates angiogenesis during PrCa progression.

PROVIDER: S-EPMC7301698 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7448905 | BioStudies
2019-01-01 | S-EPMC6411421 | BioStudies
2018-01-01 | S-EPMC5862858 | BioStudies
| S-EPMC6968621 | BioStudies
2021-01-01 | S-EPMC7962970 | BioStudies
| S-EPMC6461598 | BioStudies
2020-01-01 | S-EPMC7664451 | BioStudies
2017-01-01 | S-EPMC5405565 | BioStudies
2015-01-01 | S-EPMC4335196 | BioStudies
2020-01-01 | S-EPMC7480510 | BioStudies